Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS
Congcong Sun, Mei‐Mei Gao, Feifei Wang, et al.
Biomedical Chromatography (2020) Vol. 34, Iss. 9
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 79
Fecal Fungal Dysbiosis in Chinese Patients With Alzheimer’s Disease
Zongxin Ling, Manlian Zhu, Xia Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 45
Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship
Sofía Ramírez-Guerrero, Santiago Guardo-Maya, Germán José Medina-Rincón, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 36
Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease
Fardin Nabizadeh, Parya Valizadeh, Mohammad Sadegh Fallahi
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 7
Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls
Paniz Jasbi, Xiaojian Shi, Ping S. Chu, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 9, pp. 4303-4317
Open Access | Times Cited: 39
A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction-Related Diseases
Zebin Weng, Yuan-Rong Chen, Jin-Tao Lv, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 25
Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease
Maxime François, Avinash V. Karpe, Jianwei Liu, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 949-949
Open Access | Times Cited: 20
Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence
Meysam Amidfar, Gholamreza Askari, Yong‐Ku Kim
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 128, pp. 110848-110848
Closed Access | Times Cited: 11
Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of Neurodegeneration
Maxime François, Avinash V. Karpe, Jianwei Liu, et al.
Journal of Alzheimer s Disease (2021) Vol. 82, Iss. 3, pp. 1301-1313
Open Access | Times Cited: 24
Dysregulation of lipid metabolism, energy production, and oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Syndrome and fibromyalgia
Leah Davis, Martin R. Higgs, A Snaith, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access
NHANES-based machine learning for cognitive impairment classification and blood and hearing threshold characterization in age-related hearing loss
Zesen Zheng, Shuimei Li, Ruilin Li, et al.
Geriatric Nursing (2025) Vol. 63, pp. 8-14
Closed Access
Biomarkers for the Clinical Diagnosis of Alzheimer’s Disease: Metabolomics Analysis of Brain Tissue and Blood
Yangyang Wang, Yanping Sun, Yumeng Luo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23
Recent Advances in Understanding of Alzheimer’s Disease Progression Through Mass Spectrometry-Based Metabolomics
Jericha Mill, Lingjun Li
Phenomics (2022) Vol. 2, Iss. 1, pp. 1-17
Open Access | Times Cited: 16
A multi‐omics analysis for the prediction of neurocognitive disorders risk among the elderly in Macao
Yan Han, Xingping Quan, Yao Chen Chuang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 6
Open Access | Times Cited: 13
Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links
Arwa M. Amin, Hamza Mostafa, Hani M. J. Khojah
Clinica Chimica Acta (2022) Vol. 539, pp. 215-236
Open Access | Times Cited: 12
Synergistic effects of tilapia head protein hydrolysate and walnut protein hydrolysate on the amelioration of cognitive impairment in mice
Jun Ji, Xiangzhou Yi, Xia Gao, et al.
Journal of the Science of Food and Agriculture (2024) Vol. 104, Iss. 9, pp. 5419-5434
Closed Access | Times Cited: 2
Association of genetically predicted 486 blood metabolites on the risk of Alzheimer’s disease: a Mendelian randomization study
Qiqi Yang, Xinyu Han, Min Ye, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Tilapia Head Protein Hydrolysate Attenuates Scopolamine-Induced Cognitive Impairment through the Gut-Brain Axis in Mice
Jun Ji, Xiangzhou Yi, Yujie Zhu, et al.
Foods (2021) Vol. 10, Iss. 12, pp. 3129-3129
Open Access | Times Cited: 15
Plasma metabolites associated with cognitive function across race/ethnicities affirming the importance of healthy nutrition
Einat Granot‐Hershkovitz, Shan He, Jan Bressler, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 4, pp. 1331-1342
Open Access | Times Cited: 11
An integrated neuroimaging-omics approach for the gut-brain communication pathways in Alzheimer’s disease
Can Sheng, Wenying Du, Yuan Liang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 6
Mass spectrometry: Future opportunities for profiling and imaging steroids and steroid metabolites
Ruth Andrew, Natalie Homer
Current Opinion in Endocrine and Metabolic Research (2020) Vol. 15, pp. 71-78
Open Access | Times Cited: 16
Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease
Marina Botello‐Marabotto, M. Carmen Martínez‐Bisbal, Miguel Calero, et al.
Neurobiology of Disease (2023) Vol. 187, pp. 106312-106312
Open Access | Times Cited: 5
Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites
Diana Navas-Carrillo, José Miguel Rivera‐Caravaca, Arturo Sampedro-Andrada, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 58, Iss. 3, pp. 167-179
Closed Access | Times Cited: 14
The comprehensive mechanism underlying Schisandra polysaccharide in AD-like symptoms of Aβ25-35-induced rats based on hippocampal metabolomics and serum lipidomics techniques
Shuo Zhao, Jinpeng Zhang, Chen Yu-feng, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115717-115717
Closed Access | Times Cited: 4
Investigating metabolic dysregulation in serum of triple transgenic Alzheimer’s disease male mice: implications for pathogenesis and potential biomarkers
Hongbin Zhuang, Xueshan Cao, Xiaoxiao Tang, et al.
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top